XML 29 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
3 Months Ended
Dec. 31, 2011
Jan. 01, 2011
Operating activities:    
Net income $ 1,124,968 $ 716,536
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 217,755 193,751
Provision for losses on accounts receivable 9,000 29,000
Increase in cash value of life insurance (87,780) (57,233)
Deferred compensation (13,150) (12,175)
Stock compensation expense 18,066 13,922
Changes in operating assets and liabilities:    
Accounts receivable (497,769) 519,956
Inventories 2,498,982 (379,170)
Prepaid expenses and other assets 213,202 224,568
Accounts payable and accrued expenses (876,098) (901,367)
Net cash provided by operating activities 2,607,176 347,788
Investing activities:    
Acquisition of M.C. Healthcare (7,897,335)  
Proceeds from sale of securities available for sale 4,000,000  
Purchases of property and equipment (336,856) (73,542)
Payments for other assets (39,670) (8,338)
Net cash used for investing activities (4,273,861) (81,880)
Financing activities:    
Proceeds of long-term debt 7,000,000  
Repayment of long-term debt (6,000,000)  
Dividends paid (307,522) (275,736)
Purchase and retirement of common stock   (8,292)
Net cash provided by (used for) financing activities 692,478 (284,028)
Effect of exchange rates on cash: (7,929)  
Decrease in cash and cash equivalents (982,136) (18,120)
Cash and cash equivalents at beginning of period 2,124,406 781,195
Cash and cash equivalents at end of period $ 1,142,270 $ 763,075